Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Curriculum vitae


ORCID: 0000-0001-6169-5035


**Fellow of the Higher Education Academy, UK (FHEA), 2018

**”Title of Docent” (Dosentii) in Pharmaceutical Chemistry, University of Helsinki, Finland, 2015

**Ph.D. in Pharmaceutical Organic Chemistry, University of Coimbra, Portugal & University of Maryland, USA, (highest-scoring grade, “Passed with Distinction and Honours”), 2008

**Degree in Pharmaceutical Sciences (Pharm.D.), University of Coimbra, Portugal, Grade 17 out of 20 (First-class honours), awarded with the “ Sociedade Farmacêutica Lusitana Award” (best student of Pharmaceutical Sciences of the year in Portugal), 2003



Drug Discovery, Medicinal Chemistry, Natural Products, Antimicrobial and anti-biofilm agents & materials, Neglected diseases, Cancer, (Neuro)inflammation



The Finnish Funding Agency for Innovation (TEKES); Huonekalusäätio; University of Helsinki Research Funds; Magnus Ehrnrooth Foundation; Portuguese Science and Technology Foundation (FCT); FP7-HEALTH-2013-INNOVATION-1 (European Funding); Academy of Finland; Tenovus Scotland



Doctoral students

*Declan Mullen - Next generation bio-based antimicrobial agents, University of Strathclyde, UK

*Ghada Hassan - Sustainable antimicrobial coatings, University of Helsinki, FI

*Tiina Ahonen - New drugs for chronic pain, University of Helsinki, FI



Post-doctoral researchers

**Dr. Xing Wan, University of Helsinki, FI

**Dr. Leena Keurulainen, University of Helsinki, FI

Doctoral students

*Dr. Nina Forsman - Sustainable multifunctional coatings for textiles and other cellulosic materials (grad. 2020)

*Dr. Laura E. Kolsi - Synthesis of abietane-type diterpenoids with anticancer activity (grad. 2019)

*Dr. Raisa Haavikko - Synthesis of betulins with new bioactivities (grad. 2015)

*Dr. Nehad El-Salamouni - Design and synthesis of some novel phenolic compounds and their quinone oxidation products of potential biological activities (grad. 2013)

Fields of Science

  • 317 Pharmacy
  • Pharmaceutical Chemistry
  • Medicinal Chemistry
  • Drug repositioning
  • Natural Products
  • 116 Chemical sciences
  • Organic Chemistry
  • Steroids
  • Terpenes
  • Catalysis
  • Oxidations

International and National Collaboration Publications and projects within past five years.


Regioselective Benzylic Oxidation of Aromatic Abietanes: Application to the Semisynthesis of the Naturally Occurring Picealactones A, B and C

Kolsi, L. E., Krogerus, S., Brito, V., Rüffer, T., Lang, H., Yli-Kauhaluoma, J. T., Silvestre, S. & Moreira, V. M., 22 Aug 2017, In : ChemistrySelect. 2, 24, p. 7008-7012 5 p.

Research output: Contribution to journalArticleScientificpeer-review

Antiprotozoal activity of dehydroabietic acid derivatives against Leishmania donovani and Trypanosoma cruzi - SPECIAL ISSUE "NEW TALENT: EUROPE"

Vahermo, M., Krogerus, S., Nasereddin, A., Kaiser, M., Brun, R., Jaffe, C. L., Yli-Kauhaluoma, J. & Moreira, V. M., 2016, In : MedChemComm. 7, 3, p. 457-463 7 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

New derivatives of dehydroabietic acid target planktonic and biofilm bacteria in Staphylococcus aureus and effectively disrupt bacterial membrane integrity

Manner, S., Vahermo, M., Skogman, M., Krogerus, S., Vuorela, P. M., Yli-Kauhaluoma, J., Fallarero, A. & Moreira, V. M., 21 Jul 2015, In : European Journal of Medicinal Chemistry. 102, p. 68-79 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Drug repositioning: a machine-learning approach through data integration

Napolitano, F., Zhao, Y., Moreira, V. M., Tagliaferri, R., Kere, J., D'Amato, M. & Greco, D., 22 Jun 2013, In : Journal of Cheminformatics. 5, Article Number: 30 , 9 p.

Research output: Contribution to journalArticleScientificpeer-review

Bismuth(III) Triflate-Based Catalytic Direct Opening of Oleanolic Hydroxy-gamma-lactones to Afford 12-Oxo-28-carboxylic Acids

Salvador, J. A. R., Moreira, V. M., Pinto, R. M. A., Leal, A. S. & Le Roux, C., 10 Oct 2011, In : Advanced Synthesis & Catalysis. 353, p. 2637-2642

Research output: Contribution to journalArticleScientificpeer-review



COST Action CM1307, “Targeted chemotherapy towards diseases caused by endoparasites“ (External organisation)

Vânia M. Moreira (Member)
Jan 2016

Activity: Membership typesMembership or other role in national/international committee, council, board

Member of the International Scientific Advisory Committee of the XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC)

Vânia M. Moreira (Scientific Committee Member)
Aug 2016Sep 2016

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

Invited talk, International Caparica Christmas Congress on Translational Chemistry

Vânia M. Moreira (Speaker)
Dec 2017

Activity: Talk or presentation typesInvited talk

University of Strathclyde

Vânia M. Moreira (Visiting researcher)
May 2017Aug 2017

Activity: Visiting an external institution typesAcademic visit to other institution

New diterpenoids for chronic pain treatment

Vânia M. Moreira (Supervisor)
Jan 2016

Activity: Examination typesSupervision of other thesis (Master's, Licentiate)

Press / Media

HY news: Tutkijat kaivautuvat kivun juurille

Vânia M. Moreira


1 Media contribution

Press/Media: Press / Media

Curing prostate cancer without side effects

Vânia M. Moreira


1 Media contribution

Press/Media: Press / Media